|
BSE Code |
Company |
Date |
Purpose |
 |
530267 |
Arigato Universe
|
17-Nov-2026 |
Arigato Universe Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 inter alia to consider and approve Pursuant to Regulation 29(1)(a) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday 13th November 2026 at the Registered Office of the Company situated at Office No. Plot No. 8 Flat No. 802 28 Impressa Rise Apartment Shivaji Nagar Shankar Nagar Nagpur Maharashtra India - 440010 inter-alia to consider and approve the unaudited Financial Statement of the Quarter and Half Year ended 30th September 2026.
Arigato Universe Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/11/2026 ,inter alia, to consider and approve With reference to our prior intimation dated 04th November, 2026, we wish to inform you that the meeting of the Board of Directors of the Company, originally scheduled to be held on Friday, 13th November, 2026, has been postponed due to a delay in finalization of the accounts for the quarter and half year ended 30th September, 2026. Certain operational and reconciliation matters have required additional time, as a result of which the Limited Review process and the finalization of the Unaudited Standalone Financial Results could not be completed in time for consideration by the Audit Committee and the Board at the originally scheduled meeting. The REVISED date of the Board Meeting is Tuesday, 17th November, 2026.
(As per BSE Announcement dated on: 12.11.2026) |
 |
532172 |
Adroit Info.
|
17-Nov-2026 |
Adroit Infotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/11/2026 inter alia to consider and approve 1.To consider and approve the proposal for issuance of up to 10000000 (Once Crore) Convertible Equity Share Warrants on a preferential basis to the Promoter and Promoter Group of the Company
2.To consider and approve the change of name of the Company from Adroit Infotech Limited to Verso Altima Technologies Limited or any other name approved by the Registrar of Companies subject to the approval of shareholders stock exchanges and other regulatory authorities.
3.To consider and approve the SPA for acquisition of 60% holding in Verso Altima Group Croatia Europe.
4.To consider and approve the draft Notice of the Extra-Ordinary General Meeting including the explanatory statement pursuant to Section 102 of the Companies Act 2013 and other applicable provisions.
5.To consider any other matter with the permission of the Chair |
 |
534422 |
Looks Health
|
17-Nov-2026 |
Preferential Issue of shares & Increase in Authorised Capital |
 |
537254 |
JTL Defence
|
17-Nov-2026 |
Intimation of Meeting of Right Issue Committee to be held on 17.11.2026 |
 |
539800 |
CHD Chemicals
|
17-Nov-2026 |
Inter alia, to consider the following business: 1. To consider raising of funds pursuant to an issue of equity shares of the Company with a face value of ? 10 each (the Equity Shares ) by way of a Rights Issue to the eligible equity shareholders of the Company, subject to the receipt of applicable regulatory/statutory approvals as may be required. 2. Any other businesses, if any, which may be placed before the Board with the permission of the Chairman of the meeting. |